Accordingly, high IL-17 level is observed in colon cancer, skin cancer, and lung cancer patients with poor clinical outcome (Marshall et al., 2016; Razi et al., 2019; Bellone et al., 2020). The gene discussed is IL17A; the disease is lung cancer.